BLTE Belite Bio | $40.97 +6.5% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $59.00 | Low | View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 3/13/2024 |
ITRG Integra Resources | $0.74 -2.6% | 3/13/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $4.00 -> $3.75 | N/A | View details for HC Wainwright rating of Integra Resources (NYSEAMERICAN:ITRG) on 3/13/2024 |
BITF Bitfarms | $2.23 -1.3% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Bitfarms (NASDAQ:BITF) on 3/13/2024 |
RLYB Rallybio | $1.63 +0.6% | 3/13/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $12.00 -> $9.00 | Low | View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 3/13/2024 |
FTEK Fuel Tech | $1.09 -5.2% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Fuel Tech (NASDAQ:FTEK) on 3/13/2024 |
CRNX Crinetics Pharmaceuticals | $37.93 -2.6% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/13/2024 |
|
PRTA Prothena | $25.09 -3.8% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 | Low | View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 3/13/2024 |
INZY Inozyme Pharma | $6.00 +1.9% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 | Low | View details for HC Wainwright rating of Inozyme Pharma (NASDAQ:INZY) on 3/13/2024 |
PHUN Phunware | $10.46 -1.2% | 3/13/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Phunware (NASDAQ:PHUN) on 3/13/2024 |
TVTX Travere Therapeutics | $7.18 -4.1% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 | Low | View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 3/13/2024 |
ETNB 89bio | $12.60 -6.8% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $31.00 | Low | View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 3/13/2024 |
CYBN Cybin | $0.45 -2.2% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | N/A | View details for HC Wainwright rating of Cybin (NYSEAMERICAN:CYBN) on 3/13/2024 |
CALC CalciMedica | $3.60 -8.6% | 3/13/2024 | Reiterated by | HC Wainwright | Analyst J. Pantginis | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of CalciMedica (NASDAQ:CALC) on 3/13/2024 |
CLNN Clene | $0.41 +2.5% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 3/13/2024 |
SGMO Sangamo Therapeutics | $0.85 +9.0% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 3/13/2024 |
MOGO Mogo | $1.99 +3.1% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Mogo (NASDAQ:MOGO) on 3/14/2024 |
MIRM Mirum Pharmaceuticals | $25.98 -3.0% | 3/14/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $45.00 -> $58.00 | Low | View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 3/14/2024 |
UNCY Unicycive Therapeutics | $1.43 -2.1% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.50 | Low | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 3/14/2024 |
ECOR electroCore | $7.00 +5.4% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | | Low | View details for HC Wainwright rating of electroCore (NASDAQ:ECOR) on 3/14/2024 |
CLSD Clearside Biomedical | $1.56 -8.8% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Clearside Biomedical (NASDAQ:CLSD) on 3/14/2024 |
TARA Protara Therapeutics | $4.00 +8.7% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $23.00 | Low | View details for HC Wainwright rating of Protara Therapeutics (NASDAQ:TARA) on 3/14/2024 |
ATXS Astria Therapeutics | $15.61 +1.0% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 3/14/2024 |
PRQR ProQR Therapeutics | $2.47 -3.5% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of ProQR Therapeutics (NASDAQ:PRQR) on 3/14/2024 |
MNMD Mind Medicine (MindMed) | $9.91 +8.1% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $75.00 | Low | View details for HC Wainwright rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 3/14/2024 |
SCPH scPharmaceuticals | $5.49 -5.8% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of scPharmaceuticals (NASDAQ:SCPH) on 3/14/2024 |
JAZZ Jazz Pharmaceuticals | $123.41 +2.1% | 3/14/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $204.00 -> $200.00 | Low | View details for HC Wainwright rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 3/14/2024 |
SLDB Solid Biosciences | $13.36 +2.1% | 3/14/2024 | Reiterated by | HC Wainwright | Analyst A. He | Buy -> Buy | $16.00 | Low | View details for HC Wainwright rating of Solid Biosciences (NASDAQ:SLDB) on 3/14/2024 |
CHRS Coherus BioSciences | $2.22
| 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 | Low | View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 3/14/2024 |
KRTX Karuna Therapeutics | $329.83
| 3/14/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Neutral -> Neutral | $330.00 | N/A | View details for HC Wainwright rating of Karuna Therapeutics (NASDAQ:KRTX) on 3/14/2024 |
AGEN Agenus | $0.53 -1.9% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 3/14/2024 |
LQDA Liquidia | $15.56 -2.1% | 3/14/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $16.00 -> $32.00 | Low | View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 3/14/2024 |
FTCI FTC Solar | $0.50 +13.7% | 3/14/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $2.50 -> $1.50 | Low | View details for HC Wainwright rating of FTC Solar (NASDAQ:FTCI) on 3/14/2024 |
PHAR Pharming Group | $11.35 -1.2% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $37.00 | Low | View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 3/14/2024 |
CGEM Cullinan Oncology | $15.32 -3.8% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $34.00 | Low | View details for HC Wainwright rating of Cullinan Oncology (NASDAQ:CGEM) on 3/14/2024 |
KOPN Kopin | $2.04 +7.4% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of Kopin (NASDAQ:KOPN) on 3/15/2024 |
INAB IN8bio | $1.23 +7.9% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 | Low | View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 3/15/2024 |
VKTX Viking Therapeutics | $63.35 +1.3% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 | Low | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 3/15/2024 |
LIFE aTyr Pharma | $1.96 -1.5% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 | N/A | View details for HC Wainwright rating of aTyr Pharma (NASDAQ:LIFE) on 3/15/2024 |
TERN Terns Pharmaceuticals | $6.09 -15.5% | 3/15/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $5.50 | N/A | View details for HC Wainwright rating of Terns Pharmaceuticals (NASDAQ:TERN) on 3/15/2024 |
AKBA Akebia Therapeutics | $1.89 +11.2% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | N/A | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 3/15/2024 |
They said crypto was dead. It went up 100X. (Ad) Bitcoin’s haters are out again.
Despite the price doubling in the last six months alone…
That hasn’t stopped the experts from piling on.
Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews.
JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.”
But when it comes to cryptos, these are exactly the people you shouldn’t listen to.
They’ve predicted crypto’s demise for years. There are five coins you must take a look at right away. |
IPSC Century Therapeutics | $4.75 -5.0% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 | N/A | View details for HC Wainwright rating of Century Therapeutics (NASDAQ:IPSC) on 3/15/2024 |
CTSO Cytosorbents | $0.97 +10.3% | 3/15/2024 | Reiterated by | HC Wainwright | Analyst S. Lee | Neutral -> Neutral | $1.00 | N/A | View details for HC Wainwright rating of Cytosorbents (NASDAQ:CTSO) on 3/15/2024 |
ACIU AC Immune | $3.50
| 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 | N/A | View details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 3/15/2024 |
KZR Kezar Life Sciences | $0.87 -1.1% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | N/A | View details for HC Wainwright rating of Kezar Life Sciences (NASDAQ:KZR) on 3/15/2024 |
CODX Co-Diagnostics | $1.06 -0.9% | 3/15/2024 | Target Lowered by | HC Wainwright | - | Neutral -> Neutral | $3.00 -> $2.50 | N/A | View details for HC Wainwright rating of Co-Diagnostics (NASDAQ:CODX) on 3/15/2024 |
MDGL Madrigal Pharmaceuticals | $283.23 +4.8% | 3/15/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $405.00 -> $425.00 | N/A | View details for HC Wainwright rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/15/2024 |
GORO Gold Resource | $0.42 +10.5% | 3/15/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.75 -> $1.50 | N/A | View details for HC Wainwright rating of Gold Resource (NYSE:GORO) on 3/15/2024 |
VGZ Vista Gold | $0.52 -1.9% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 | N/A | View details for HC Wainwright rating of Vista Gold (NYSE:VGZ) on 3/15/2024 |
IPA ImmunoPrecise Antibodies | $1.40 -2.8% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | N/A | View details for HC Wainwright rating of ImmunoPrecise Antibodies (NASDAQ:IPA) on 3/15/2024 |
VIR Vir Biotechnology | $10.68 -0.7% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $110.00 | N/A | View details for HC Wainwright rating of Vir Biotechnology (NASDAQ:VIR) on 3/15/2024 |
LBPH Longboard Pharmaceuticals | $20.48 +6.0% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $60.00 | Low | View details for HC Wainwright rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 3/15/2024 |
SLN Silence Therapeutics | $24.01 +5.1% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $75.00 | Low | View details for HC Wainwright rating of Silence Therapeutics (NASDAQ:SLN) on 3/15/2024 |
TRDA Entrada Therapeutics | $12.41 -2.9% | 3/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Entrada Therapeutics (NASDAQ:TRDA) on 3/18/2024 |
LEGN Legend Biotech | $64.66 +1.0% | 3/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $87.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 3/18/2024 |
IMAB I-Mab | $1.81 -2.7% | 3/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 -> $8.00 | Low | View details for HC Wainwright rating of I-Mab (NASDAQ:IMAB) on 3/18/2024 |
BDTX Black Diamond Therapeutics | $4.70 -1.9% | 3/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $12.00 | Low | View details for HC Wainwright rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 3/18/2024 |
AQST Aquestive Therapeutics | $5.51 -9.5% | 3/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $7.00 -> $9.00 | Low | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 3/18/2024 |
URGN UroGen Pharma | $14.50 +0.3% | 3/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $54.00 | Low | View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 3/18/2024 |
BTAI BioXcel Therapeutics | $2.74 +2.2% | 3/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of BioXcel Therapeutics (NASDAQ:BTAI) on 3/18/2024 |
OPTN OptiNose | $1.94 +3.2% | 3/18/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of OptiNose (NASDAQ:OPTN) on 3/18/2024 |
RGLS Regulus Therapeutics | $2.36 +11.8% | 3/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Regulus Therapeutics (NASDAQ:RGLS) on 3/18/2024 |
SPRO Spero Therapeutics | $1.73 -3.4% | 3/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Spero Therapeutics (NASDAQ:SPRO) on 3/18/2024 |
ASLN ASLAN Pharmaceuticals | $0.80 +23.1% | 3/18/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $17.00 -> $9.00 | Low | View details for HC Wainwright rating of ASLAN Pharmaceuticals (NASDAQ:ASLN) on 3/18/2024 |
RNAC Cartesian Therapeutics | $0.63 +8.6% | 3/18/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $2.00 | Low | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 3/18/2024 |
BLNK Blink Charging | $2.72 -7.2% | 3/18/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $25.00 -> $15.00 | Low | View details for HC Wainwright rating of Blink Charging (NASDAQ:BLNK) on 3/18/2024 |
BWAY BrainsWay | $6.06 +4.3% | 3/11/2024 | Reiterated by | HC Wainwright | Analyst B. Pachaiyappan | Buy | | Low | View details for HC Wainwright rating of BrainsWay (NASDAQ:BWAY) on 3/11/2024 |
SPRB Spruce Biosciences | $0.76 -6.2% | 3/14/2024 | Downgraded by | HC Wainwright | - | Buy -> Neutral | | Low | View details for HC Wainwright rating of Spruce Biosciences (NASDAQ:SPRB) on 3/14/2024 |
RGNX REGENXBIO | $22.33 +0.6% | 3/11/2024 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy | $36.00 | Low | View details for HC Wainwright rating of REGENXBIO (NASDAQ:RGNX) on 3/11/2024 |
OPTN OptiNose | $1.94 +3.2% | 3/11/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy | $5.00 | Low | View details for HC Wainwright rating of OptiNose (NASDAQ:OPTN) on 3/11/2024 |
AEYE AudioEye | $9.03 +3.2% | 3/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $8.00 -> $10.00 | Low | View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 3/7/2024 |
URG Ur-Energy | $1.48 +0.7% | 3/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $2.70 -> $3.60 | N/A | View details for HC Wainwright rating of Ur-Energy (NYSEAMERICAN:URG) on 3/7/2024 |
NUVB Nuvation Bio | $2.26 -0.9% | 3/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $4.50 -> $5.00 | Low | View details for HC Wainwright rating of Nuvation Bio (NYSE:NUVB) on 3/7/2024 |
PHGE BiomX | $0.36 -2.7% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 | N/A | View details for HC Wainwright rating of BiomX (NYSEAMERICAN:PHGE) on 3/7/2024 |
PMVP PMV Pharmaceuticals | $1.67 -5.1% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of PMV Pharmaceuticals (NASDAQ:PMVP) on 3/7/2024 |
TLPH Talphera | $1.15
| 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Talphera (NASDAQ:TLPH) on 3/7/2024 |
HTOO Fusion Fuel Green | $1.65 +11.5% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.50 | Low | View details for HC Wainwright rating of Fusion Fuel Green (NASDAQ:HTOO) on 3/7/2024 |
SDIG Stronghold Digital Mining | $3.90 -4.9% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Stronghold Digital Mining (NASDAQ:SDIG) on 3/7/2024 |
WVE Wave Life Sciences | $5.67 -12.8% | 3/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $8.00 -> $15.00 | Low | View details for HC Wainwright rating of Wave Life Sciences (NASDAQ:WVE) on 3/7/2024 |
ITOS iTeos Therapeutics | $10.26 -5.1% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $44.00 | N/A | View details for HC Wainwright rating of iTeos Therapeutics (NASDAQ:ITOS) on 3/7/2024 |
XERS Xeris Biopharma | $2.13 -4.5% | 3/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.50 -> $6.00 | N/A | View details for HC Wainwright rating of Xeris Biopharma (NASDAQ:XERS) on 3/7/2024 |
RZLT Rezolute | $1.79 +0.6% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 | N/A | View details for HC Wainwright rating of Rezolute (NASDAQ:RZLT) on 3/7/2024 |
KMDA Kamada | $5.87 +4.8% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | N/A | View details for HC Wainwright rating of Kamada (NASDAQ:KMDA) on 3/7/2024 |
TCRX TScan Therapeutics | $6.83 -4.1% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | N/A | View details for HC Wainwright rating of TScan Therapeutics (NASDAQ:TCRX) on 3/7/2024 |
ELEV Elevation Oncology | $4.36 -0.7% | 3/7/2024 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $6.00 | N/A | View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 3/7/2024 |
BWEN Broadwind | $2.26 +1.8% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Broadwind (NASDAQ:BWEN) on 3/6/2024 |
DYN Dyne Therapeutics | $26.28 -6.1% | 3/6/2024 | Reiterated by | HC Wainwright | Analyst A. Fein | Buy -> Buy | $36.00 | Low | View details for HC Wainwright rating of Dyne Therapeutics (NASDAQ:DYN) on 3/6/2024 |
BMEA Biomea Fusion | $15.77 -11.7% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 3/6/2024 |
KURA Kura Oncology | $21.04 -5.8% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $32.00 | Low | View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 3/6/2024 |
ITRM Iterum Therapeutics | $1.63 +11.6% | 3/6/2024 | Reiterated by | HC Wainwright | Analyst E. Arce | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Iterum Therapeutics (NASDAQ:ITRM) on 3/6/2024 |
RIGL Rigel Pharmaceuticals | $1.34 -1.5% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 3/6/2024 |
They said crypto was dead. It went up 100X. (Ad) Bitcoin’s haters are out again.
Despite the price doubling in the last six months alone…
That hasn’t stopped the experts from piling on.
Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews.
JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.”
But when it comes to cryptos, these are exactly the people you shouldn’t listen to.
They’ve predicted crypto’s demise for years. There are five coins you must take a look at right away. |
GOSS Gossamer Bio | $1.38 -5.5% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Gossamer Bio (NASDAQ:GOSS) on 3/6/2024 |
ADCT ADC Therapeutics | $4.42 +16.9% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 3/6/2024 |
EYEN Eyenovia | $1.53 -3.8% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Eyenovia (NASDAQ:EYEN) on 3/6/2024 |
IMCR Immunocore | $60.49 -0.6% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 | Low | View details for HC Wainwright rating of Immunocore (NASDAQ:IMCR) on 3/6/2024 |
IOBT IO Biotech | $1.58 -4.2% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of IO Biotech (NASDAQ:IOBT) on 3/6/2024 |
GRTS Gritstone bio | $2.47 +3.8% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Gritstone bio (NASDAQ:GRTS) on 3/6/2024 |
SWTX SpringWorks Therapeutics | $48.43 -3.7% | 3/6/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $73.00 -> $74.00 | Low | View details for HC Wainwright rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 3/6/2024 |
CECO CECO Environmental | $21.47 +0.7% | 3/6/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $22.00 -> $30.00 | Low | View details for HC Wainwright rating of CECO Environmental (NASDAQ:CECO) on 3/6/2024 |
TCON TRACON Pharmaceuticals | $0.36 -2.7% | 3/6/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $7.00 -> $6.00 | Low | View details for HC Wainwright rating of TRACON Pharmaceuticals (NASDAQ:TCON) on 3/6/2024 |
CRDF Cardiff Oncology | $5.17 +2.8% | 3/6/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $12.00 -> $14.00 | Low | View details for HC Wainwright rating of Cardiff Oncology (NASDAQ:CRDF) on 3/6/2024 |
MRNS Marinus Pharmaceuticals | $9.02 -3.9% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 3/6/2024 |
PRAX Praxis Precision Medicines | $54.57 -1.0% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $105.00 | Low | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 3/6/2024 |
GMAB Genmab A/S | $29.69 -0.8% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 3/6/2024 |
YMAB Y-mAbs Therapeutics | $13.76 -6.4% | 3/6/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $21.00 -> $22.00 | Low | View details for HC Wainwright rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 3/6/2024 |
ALNY Alnylam Pharmaceuticals | $147.41 -1.2% | 3/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $395.00 | Low | View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 3/5/2024 |
PPBT Purple Biotech | $0.69 -4.2% | 3/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Purple Biotech (NASDAQ:PPBT) on 3/5/2024 |
CIFR Cipher Mining | $3.95 +11.9% | 3/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.50 | Low | View details for HC Wainwright rating of Cipher Mining (NASDAQ:CIFR) on 3/5/2024 |
EKSO Ekso Bionics | $1.34 +1.5% | 3/5/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $9.25 | Low | View details for HC Wainwright rating of Ekso Bionics (NASDAQ:EKSO) on 3/5/2024 |
IKT Inhibikase Therapeutics | $2.01 -4.7% | 3/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of Inhibikase Therapeutics (NYSE:IKT) on 3/5/2024 |
ICCM IceCure Medical | $1.22 +0.8% | 3/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 3/5/2024 |
NGNE Neurogene | $37.55 +0.1% | 3/5/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $45.00 | Low | View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 3/5/2024 |
ZVRA Zevra Therapeutics | $5.96 -0.7% | 3/5/2024 | Reiterated by | HC Wainwright | Analyst O. Livnat | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 3/5/2024 |
SAVA Cassava Sciences | $21.28 0.0% | 3/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $124.00 | Low | View details for HC Wainwright rating of Cassava Sciences (NASDAQ:SAVA) on 3/5/2024 |
ATXS Astria Therapeutics | $15.61 +1.0% | 3/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 3/5/2024 |
UNCY Unicycive Therapeutics | $1.43 -2.1% | 3/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.50 | Low | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 3/5/2024 |
AVDL Avadel Pharmaceuticals | $15.77 -0.9% | 3/5/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $21.00 -> $25.00 | Low | View details for HC Wainwright rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 3/5/2024 |
BTDR Bitdeer Technologies Group | $7.40 -7.5% | 3/4/2024 | Reiterated by | HC Wainwright | Analyst M. Colonnese | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 3/4/2024 |
GHRS GH Research | $10.81 -0.8% | 3/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 | Low | View details for HC Wainwright rating of GH Research (NASDAQ:GHRS) on 3/4/2024 |
LLAP Terran Orbital | $1.18 -4.1% | 3/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of Terran Orbital (NYSE:LLAP) on 3/4/2024 |
SOUN SoundHound AI | $8.24 -7.5% | 3/4/2024 | Target Raised by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $5.00 -> $7.00 | Low | View details for HC Wainwright rating of SoundHound AI (NASDAQ:SOUN) on 3/4/2024 |
BHVN Biohaven | $56.73 -0.6% | 3/4/2024 | Target Raised by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $50.00 -> $63.00 | Low | View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 3/4/2024 |
ANIP ANI Pharmaceuticals | $67.62 +2.5% | 3/4/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $73.00 -> $83.00 | Low | View details for HC Wainwright rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 3/4/2024 |
ATEC Alphatec | $13.51 +3.2% | 3/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Alphatec (NASDAQ:ATEC) on 3/4/2024 |
ANNX Annexon | $6.29 -6.0% | 3/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Annexon (NASDAQ:ANNX) on 3/4/2024 |
RNAC Cartesian Therapeutics | $0.63 +8.6% | 3/4/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $2.00 | Low | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 3/4/2024 |
PCRX Pacira BioSciences | $29.29 -0.4% | 3/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $57.00 | Low | View details for HC Wainwright rating of Pacira BioSciences (NASDAQ:PCRX) on 3/4/2024 |
MUX McEwen Mining | $8.47 -1.5% | 3/4/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $18.50 -> $13.00 | Low | View details for HC Wainwright rating of McEwen Mining (NYSE:MUX) on 3/4/2024 |
VRNA Verona Pharma | $15.53 -0.8% | 3/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $32.00 | Low | View details for HC Wainwright rating of Verona Pharma (NASDAQ:VRNA) on 3/4/2024 |
CNTB Connect Biopharma | $1.24 -4.6% | 3/4/2024 | Initiated by | HC Wainwright | Analyst E. Bodnar | Buy | $7.00 | Low | View details for HC Wainwright rating of Connect Biopharma (NASDAQ:CNTB) on 3/4/2024 |
MLTX MoonLake Immunotherapeutics | $48.56 +2.8% | 3/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $75.00 | Low | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 3/4/2024 |
BBIO BridgeBio Pharma | $27.81 +0.9% | 3/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $47.00 | Low | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 3/4/2024 |
AXSM Axsome Therapeutics | $72.54 -4.0% | 3/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $180.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 3/4/2024 |
PBYI Puma Biotechnology | $4.66 -6.8% | 3/1/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $8.00 -> $7.00 | Low | View details for HC Wainwright rating of Puma Biotechnology (NASDAQ:PBYI) on 3/1/2024 |
AKRO Akero Therapeutics | $26.84 -2.5% | 3/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $40.00 -> $43.00 | Low | View details for HC Wainwright rating of Akero Therapeutics (NASDAQ:AKRO) on 3/1/2024 |
AUPH Aurinia Pharmaceuticals | $5.09 -1.5% | 3/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 | Low | View details for HC Wainwright rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 3/1/2024 |
QURE uniQure | $4.97 -3.9% | 3/1/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $30.00 -> $25.00 | Low | View details for HC Wainwright rating of uniQure (NASDAQ:QURE) on 3/1/2024 |
MNMD Mind Medicine (MindMed) | $9.91 +8.1% | 3/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $75.00 | Low | View details for HC Wainwright rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 3/1/2024 |
EOLS Evolus | $14.00 +0.7% | 3/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of Evolus (NASDAQ:EOLS) on 3/1/2024 |
CMPS COMPASS Pathways | $9.79 -1.1% | 3/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $120.00 | Low | View details for HC Wainwright rating of COMPASS Pathways (NASDAQ:CMPS) on 3/1/2024 |
CPRX Catalyst Pharmaceuticals | $16.08 +0.1% | 3/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $24.00 | Low | View details for HC Wainwright rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/1/2024 |
Did you make $29,000 two days with AI options trades? (Ad) What if it was possible to find options trades on autopilot…
Using A.I. to find the ones with the highest profit potential…
And nearly perfect win rates…
You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below: Click Here To Get Your Free Copy |
KROS Keros Therapeutics | $63.86 -5.2% | 3/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $100.00 | Low | View details for HC Wainwright rating of Keros Therapeutics (NASDAQ:KROS) on 3/1/2024 |
LSTA Lisata Therapeutics | $3.04 -1.3% | 3/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Lisata Therapeutics (NASDAQ:LSTA) on 3/1/2024 |
CAPR Capricor Therapeutics | $6.76 +5.8% | 3/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 | Low | View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 3/1/2024 |
STTK Shattuck Labs | $8.27 -5.1% | 3/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 | Low | View details for HC Wainwright rating of Shattuck Labs (NASDAQ:STTK) on 3/1/2024 |
USAU U.S. Gold | $3.50 -1.7% | 3/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of U.S. Gold (NASDAQ:USAU) on 3/1/2024 |
SANA Sana Biotechnology | $8.91 +0.3% | 3/1/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Sana Biotechnology (NASDAQ:SANA) on 3/1/2024 |
ARGX argenx | $361.54 -2.6% | 3/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $451.00 | Low | View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 3/1/2024 |
VRCA Verrica Pharmaceuticals | $4.75 -1.0% | 3/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $12.00 -> $13.00 | Low | View details for HC Wainwright rating of Verrica Pharmaceuticals (NASDAQ:VRCA) on 3/1/2024 |
ZYXI Zynex | $12.65 +0.8% | 3/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $20.00 -> $21.00 | Low | View details for HC Wainwright rating of Zynex (NASDAQ:ZYXI) on 3/1/2024 |
KPTI Karyopharm Therapeutics | $1.47 -2.6% | 3/1/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $8.00 | Low | View details for HC Wainwright rating of Karyopharm Therapeutics (NASDAQ:KPTI) on 3/1/2024 |
CMRX Chimerix | $1.10 -4.3% | 3/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Chimerix (NASDAQ:CMRX) on 3/1/2024 |
ETNB 89bio | $12.60 -6.8% | 3/1/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $32.00 -> $31.00 | Low | View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 3/1/2024 |
ABUS Arbutus Biopharma | $2.54 -3.1% | 3/1/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $6.00 -> $5.00 | Low | View details for HC Wainwright rating of Arbutus Biopharma (NASDAQ:ABUS) on 3/1/2024 |
NVAX Novavax | $5.14 -2.8% | 3/1/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $35.00 -> $19.00 | Low | View details for HC Wainwright rating of Novavax (NASDAQ:NVAX) on 3/1/2024 |
QSI Quantum-Si | $1.91 +10.4% | 3/1/2024 | Target Raised by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $3.00 -> $4.00 | Low | View details for HC Wainwright rating of Quantum-Si (NASDAQ:QSI) on 3/1/2024 |
VCEL Vericel | $44.19 -0.2% | 3/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $46.00 -> $53.00 | Low | View details for HC Wainwright rating of Vericel (NASDAQ:VCEL) on 3/1/2024 |
FDMT 4D Molecular Therapeutics | $31.03 -1.5% | 3/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $36.00 | Low | View details for HC Wainwright rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 3/1/2024 |
VALN Valneva | $7.74 +0.4% | 2/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $26.00 | Low | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 2/29/2024 |
VYNE VYNE Therapeutics | $1.92 -4.5% | 2/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.75 | Low | View details for HC Wainwright rating of VYNE Therapeutics (NASDAQ:VYNE) on 2/29/2024 |
MIRM Mirum Pharmaceuticals | $25.98 -3.0% | 2/29/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $58.00 -> $45.00 | Low | View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 2/29/2024 |
RVNC Revance Therapeutics | $4.94 -6.8% | 2/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Revance Therapeutics (NASDAQ:RVNC) on 2/29/2024 |
VRDN Viridian Therapeutics | $17.34 +1.5% | 2/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $37.00 | Low | View details for HC Wainwright rating of Viridian Therapeutics (NASDAQ:VRDN) on 2/29/2024 |
LYEL Lyell Immunopharma | $2.08 -3.7% | 2/29/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $8.00 -> $6.00 | Low | View details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 2/29/2024 |
MRUS Merus | $44.32 +1.0% | 2/29/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $48.00 -> $65.00 | Low | View details for HC Wainwright rating of Merus (NASDAQ:MRUS) on 2/29/2024 |
ACLX Arcellx | $69.11 -2.1% | 2/29/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $60.00 -> $82.00 | Low | View details for HC Wainwright rating of Arcellx (NASDAQ:ACLX) on 2/29/2024 |
ASPI ASP Isotopes | $4.67 +15.9% | 2/29/2024 | Target Raised by | HC Wainwright | Analyst H. Ihle | Buy -> Buy | $3.25 -> $5.25 | Low | View details for HC Wainwright rating of ASP Isotopes (NASDAQ:ASPI) on 2/29/2024 |
BLRX BioLineRx | $1.15
| 2/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | Low | View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 2/29/2024 |
IOVA Iovance Biotherapeutics | $14.03 +0.9% | 2/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $32.00 | Low | View details for HC Wainwright rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 2/29/2024 |
LGND Ligand Pharmaceuticals | $72.14 +1.5% | 2/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $144.00 | Low | View details for HC Wainwright rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 2/29/2024 |
MARA Marathon Digital | $19.41 +0.5% | 2/29/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $24.00 -> $35.00 | Low | View details for HC Wainwright rating of Marathon Digital (NASDAQ:MARA) on 2/29/2024 |
VTNR Vertex Energy | $1.16 -5.7% | 2/29/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $8.00 -> $3.50 | Low | View details for HC Wainwright rating of Vertex Energy (NASDAQ:VTNR) on 2/29/2024 |
OCS Oculis | $11.85 +4.2% | 2/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $29.00 | Low | View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 2/29/2024 |
ADMA ADMA Biologics | $5.94 -0.8% | 2/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of ADMA Biologics (NASDAQ:ADMA) on 2/29/2024 |
CBAY CymaBay Therapeutics | $32.46 +0.0% | 2/29/2024 | Reiterated by | HC Wainwright | Analyst E. Arce | Neutral -> Neutral | $32.50 | Low | View details for HC Wainwright rating of CymaBay Therapeutics (NASDAQ:CBAY) on 2/29/2024 |
FULC Fulcrum Therapeutics | $10.12 -10.9% | 2/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $14.00 -> $17.00 | Low | View details for HC Wainwright rating of Fulcrum Therapeutics (NASDAQ:FULC) on 2/28/2024 |
PTN Palatin Technologies | $1.60 +3.9% | 2/28/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $70.00 -> $17.00 | N/A | View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 2/28/2024 |
CYTK Cytokinetics | $63.75 -2.2% | 2/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $94.00 | Low | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 2/28/2024 |
ESPR Esperion Therapeutics | $2.05 -1.0% | 2/28/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $22.00 -> $16.00 | Low | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 2/28/2024 |
GLSI Greenwich LifeSciences | $17.03 -2.7% | 2/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $36.00 | Low | View details for HC Wainwright rating of Greenwich LifeSciences (NASDAQ:GLSI) on 2/28/2024 |
OPK OPKO Health | $0.87 -3.4% | 2/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 2/28/2024 |
KURA Kura Oncology | $21.04 -5.8% | 2/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $32.00 | Low | View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 2/28/2024 |
SNDX Syndax Pharmaceuticals | $21.92 -6.8% | 2/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $41.00 | Low | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 2/28/2024 |
TARS Tarsus Pharmaceuticals | $30.61 -3.1% | 2/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $50.00 -> $57.00 | Low | View details for HC Wainwright rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 2/28/2024 |
EMX EMX Royalty | $1.71 -1.2% | 2/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.75 -> $6.50 | N/A | View details for HC Wainwright rating of EMX Royalty (NYSEAMERICAN:EMX) on 2/28/2024 |
ARVN Arvinas | $42.60 -5.0% | 2/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 | Low | View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 2/28/2024 |
DNLI Denali Therapeutics | $20.09 -0.2% | 2/28/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $105.00 -> $95.00 | Low | View details for HC Wainwright rating of Denali Therapeutics (NASDAQ:DNLI) on 2/28/2024 |
TGTX TG Therapeutics | $15.05 -1.1% | 2/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $45.00 | Low | View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 2/28/2024 |
CLSK CleanSpark | $17.46 +0.2% | 2/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $15.00 -> $27.00 | Low | View details for HC Wainwright rating of CleanSpark (NASDAQ:CLSK) on 2/28/2024 |
RIOT Riot Platforms | $11.43 -1.5% | 2/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $19.00 -> $20.00 | N/A | View details for HC Wainwright rating of Riot Platforms (NASDAQ:RIOT) on 2/28/2024 |
ZNTL Zentalis Pharmaceuticals | $13.86 -3.2% | 2/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $46.00 | Low | View details for HC Wainwright rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 2/28/2024 |
Like Tiny Crypto Retirement Funds (Ad) The crypto bull market is about to blast off.
Bitcoin and Ethereum are surging.
But so are tiny altcoins that could be so profitable…
They're like tiny crypto retirement funds.
Click here and see how to get a copy. |
PLRX Pliant Therapeutics | $14.60 -3.9% | 2/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $48.00 | Low | View details for HC Wainwright rating of Pliant Therapeutics (NASDAQ:PLRX) on 2/28/2024 |
ACXP Acurx Pharmaceuticals | $2.59 -4.8% | 2/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 | Low | View details for HC Wainwright rating of Acurx Pharmaceuticals (NASDAQ:ACXP) on 2/28/2024 |
APLS Apellis Pharmaceuticals | $56.26 -0.8% | 2/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $92.00 | Low | View details for HC Wainwright rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 2/28/2024 |
LFWD ReWalk Robotics | $4.14 -12.3% | 2/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | Low | View details for HC Wainwright rating of ReWalk Robotics (NASDAQ:LFWD) on 2/28/2024 |
ALEC Alector | $6.00 -2.0% | 2/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $41.00 | Low | View details for HC Wainwright rating of Alector (NASDAQ:ALEC) on 2/28/2024 |
ACAD ACADIA Pharmaceuticals | $18.72 +1.3% | 2/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $33.00 | Low | View details for HC Wainwright rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 2/28/2024 |
PTGX Protagonist Therapeutics | $28.46 -1.8% | 2/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $38.00 | Low | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 2/28/2024 |
NERV Minerva Neurosciences | $2.70 -3.2% | 2/27/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $11.00 | N/A | View details for HC Wainwright rating of Minerva Neurosciences (NASDAQ:NERV) on 2/27/2024 |
HUT Hut 8 | $7.79 +3.3% | 2/27/2024 | Reiterated by | HC Wainwright | Analyst M. Colonnese | Sell -> Sell | $7.00 | Low | View details for HC Wainwright rating of Hut 8 (NASDAQ:HUT) on 2/27/2024 |
PPBT Purple Biotech | $0.69 -4.2% | 2/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Purple Biotech (NASDAQ:PPBT) on 2/27/2024 |
VKTX Viking Therapeutics | $63.35 +1.3% | 2/27/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $33.00 -> $90.00 | N/A | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 2/27/2024 |
TYGO Tigo Energy | $0.98 -3.0% | 2/27/2024 | Initiated by | HC Wainwright | Analyst A. Dayal | Buy | $5.00 | Low | View details for HC Wainwright rating of Tigo Energy (NASDAQ:TYGO) on 2/27/2024 |
MIST Milestone Pharmaceuticals | $1.49 +2.8% | 2/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of Milestone Pharmaceuticals (NASDAQ:MIST) on 2/26/2024 |
RVNC Revance Therapeutics | $4.94 -6.8% | 2/23/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $15.00 -> $12.00 | Low | View details for HC Wainwright rating of Revance Therapeutics (NASDAQ:RVNC) on 2/23/2024 |
NVCR NovoCure | $13.82 -1.1% | 2/22/2024 | Target Raised by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $21.00 -> $22.00 | Low | View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 2/22/2024 |
VGCX Victoria Gold | C$6.21 -2.4% | 2/22/2024 | Target Lowered by | HC Wainwright | - | | C$24.00 -> C$12.00 | N/A | View details for HC Wainwright rating of Victoria Gold (TSE:VGCX) on 2/22/2024 |
CLNN Clene | $0.41 +2.5% | 2/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 2/22/2024 |
RIGL Rigel Pharmaceuticals | $1.34 -1.5% | 2/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 2/22/2024 |
CALT Calliditas Therapeutics AB (publ) | $21.62 -3.0% | 2/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Calliditas Therapeutics AB (publ) (NASDAQ:CALT) on 2/22/2024 |
SLN Silence Therapeutics | $24.01 +5.1% | 2/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $75.00 | Low | View details for HC Wainwright rating of Silence Therapeutics (NASDAQ:SLN) on 2/22/2024 |
AUPH Aurinia Pharmaceuticals | $5.09 -1.5% | 2/22/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $15.00 -> $13.00 | Low | View details for HC Wainwright rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 2/22/2024 |
OCGN Ocugen | $1.03 -4.6% | 2/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Ocugen (NASDAQ:OCGN) on 2/22/2024 |
UTHR United Therapeutics | $233.97 -0.8% | 2/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $300.00 | Low | View details for HC Wainwright rating of United Therapeutics (NASDAQ:UTHR) on 2/22/2024 |
DNLI Denali Therapeutics | $20.09 -0.2% | 2/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $105.00 | Low | View details for HC Wainwright rating of Denali Therapeutics (NASDAQ:DNLI) on 2/22/2024 |
PRPH ProPhase Labs | $5.14 +2.0% | 2/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of ProPhase Labs (NASDAQ:PRPH) on 2/21/2024 |
LIFE aTyr Pharma | $1.96 -1.5% | 2/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 | Low | View details for HC Wainwright rating of aTyr Pharma (NASDAQ:LIFE) on 2/21/2024 |
RPTX Repare Therapeutics | $5.17 -2.3% | 2/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Repare Therapeutics (NASDAQ:RPTX) on 2/21/2024 |
HALO Halozyme Therapeutics | $40.37 -1.2% | 2/21/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $48.00 -> $50.00 | Low | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 2/21/2024 |
DBVT DBV Technologies | $0.76 -3.8% | 2/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of DBV Technologies (NASDAQ:DBVT) on 2/21/2024 |
BCYC Bicycle Therapeutics | $24.12 +1.5% | 2/21/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $57.00 -> $55.00 | Low | View details for HC Wainwright rating of Bicycle Therapeutics (NASDAQ:BCYC) on 2/21/2024 |
RAPT RAPT Therapeutics | $8.33 -1.7% | 2/21/2024 | Downgraded by | HC Wainwright | Analyst R. Selvaraju | Buy -> Neutral | | Low | View details for HC Wainwright rating of RAPT Therapeutics (NASDAQ:RAPT) on 2/21/2024 |
RVPH Reviva Pharmaceuticals | $3.08 -2.2% | 2/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 2/20/2024 |
GMAB Genmab A/S | $29.69 -0.8% | 2/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 2/20/2024 |
ADCT ADC Therapeutics | $4.42 +16.9% | 2/20/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $3.00 -> $9.00 | Low | View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 2/20/2024 |
YMAB Y-mAbs Therapeutics | $13.76 -6.4% | 2/20/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $11.00 -> $21.00 | Low | View details for HC Wainwright rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 2/20/2024 |
NRIX Nurix Therapeutics | $12.84 -1.8% | 2/20/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $35.00 -> $19.00 | Low | View details for HC Wainwright rating of Nurix Therapeutics (NASDAQ:NRIX) on 2/20/2024 |
GAU Galiano Gold | $1.13 -5.8% | 2/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.20 | N/A | View details for HC Wainwright rating of Galiano Gold (NYSEAMERICAN:GAU) on 2/20/2024 |
GLSI Greenwich LifeSciences | $17.03 -2.7% | 2/20/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $38.00 -> $36.00 | Low | View details for HC Wainwright rating of Greenwich LifeSciences (NASDAQ:GLSI) on 2/20/2024 |
ELEV Elevation Oncology | $4.36 -0.7% | 2/20/2024 | Target Raised by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $1.50 -> $6.00 | Low | View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 2/20/2024 |
PRLD Prelude Therapeutics | $4.65 -1.9% | 2/20/2024 | Downgraded by | HC Wainwright | Analyst R. Burns | Buy -> Neutral | $5.00 | Low | View details for HC Wainwright rating of Prelude Therapeutics (NASDAQ:PRLD) on 2/20/2024 |
DYN Dyne Therapeutics | $26.28 -6.1% | 2/20/2024 | Initiated by | HC Wainwright | Analyst A. Fein | Buy | $36.00 | Low | View details for HC Wainwright rating of Dyne Therapeutics (NASDAQ:DYN) on 2/20/2024 |
XOMA XOMA | $25.18 -4.3% | 2/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $74.00 | Low | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 2/16/2024 |
COIN Coinbase Global | $239.62 -1.1% | 2/16/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $115.00 -> $250.00 | Low | View details for HC Wainwright rating of Coinbase Global (NASDAQ:COIN) on 2/16/2024 |
SAGE Sage Therapeutics | $19.37 -3.0% | 2/15/2024 | Target Raised by | HC Wainwright | - | Neutral -> Neutral | $25.00 -> $28.00 | Low | View details for HC Wainwright rating of Sage Therapeutics (NASDAQ:SAGE) on 2/15/2024 |
PTN Palatin Technologies | $1.60 +3.9% | 2/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $70.00 | N/A | View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 2/15/2024 |
CYBN Cybin | $0.45 -2.2% | 2/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | N/A | View details for HC Wainwright rating of Cybin (NYSEAMERICAN:CYBN) on 2/15/2024 |
VALN Valneva | $7.74 +0.4% | 2/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $26.00 | Low | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 2/15/2024 |
CTXR Citius Pharmaceuticals | $0.72 -2.7% | 2/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 2/14/2024 |
DTIL Precision BioSciences | $11.73 +4.1% | 2/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | | N/A | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 2/14/2024 |
ONCY Oncolytics Biotech | $1.04 +5.1% | 2/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 2/14/2024 |
ROIV Roivant Sciences | $9.87 -2.7% | 2/14/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $18.00 -> $17.00 | Low | View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 2/14/2024 |
RZLT Rezolute | $1.79 +0.6% | 2/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 | Low | View details for HC Wainwright rating of Rezolute (NASDAQ:RZLT) on 2/14/2024 |
OCUL Ocular Therapeutix | $9.44 -0.2% | 2/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 2/14/2024 |
EDSA Edesa Biotech | $4.30 -2.1% | 2/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | Low | View details for HC Wainwright rating of Edesa Biotech (NASDAQ:EDSA) on 2/14/2024 |
KALV KalVista Pharmaceuticals | $11.99 +0.5% | 2/14/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $16.00 -> $24.00 | Low | View details for HC Wainwright rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 2/14/2024 |
VIR Vir Biotechnology | $10.68 -0.7% | 2/14/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $85.00 -> $110.00 | Low | View details for HC Wainwright rating of Vir Biotechnology (NASDAQ:VIR) on 2/14/2024 |
BIIB Biogen | $219.40 +0.0% | 2/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $325.00 | Low | View details for HC Wainwright rating of Biogen (NASDAQ:BIIB) on 2/14/2024 |
RPTX Repare Therapeutics | $5.17 -2.3% | 2/14/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $25.00 -> $10.00 | Low | View details for HC Wainwright rating of Repare Therapeutics (NASDAQ:RPTX) on 2/14/2024 |
ASPN Aspen Aerogels | $15.41 +0.9% | 2/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Aspen Aerogels (NYSE:ASPN) on 2/14/2024 |
HIVE HIVE Digital Technologies | $2.97 -3.3% | 2/14/2024 | Reiterated by | HC Wainwright | Analyst M. Colonnese | Neutral -> Neutral | $3.50 | Low | View details for HC Wainwright rating of HIVE Digital Technologies (NASDAQ:HIVE) on 2/14/2024 |